旅行疫苗市场规模、份额和成长分析（按疫苗类型、疾病、旅行者类型和地区划分）－2026-2033年产业预测

全球旅游疫苗市场规模预计在 2024 年达到 43.1 亿美元，从 2025 年的 45.4 亿美元成长到 2033 年的 68.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.2%。

全球旅行疫苗市场正经历显着成长，这主要受多种因素影响，包括供需两端。休閒、商务和教育等国际旅行的激增推动了对特定地点疫苗的需求，这对于预防当地感染至关重要。全球旅游业的蓬勃发展，尤其是生态旅游和探险旅游，进一步凸显了疫苗接种的必要性。民众和政府对感染疾病疫情的日益关注也推动了全球疫苗需求。此外，各国对疫苗接种证书的监管要求也创造了合规性和市场机会。疫苗研发技术的创新，包括mRNA和重组技术，提高了疫苗的效力并加快了生产速度，增加了人们对这些疫苗的依赖。不断上涨的医疗保健成本以及旨在加强旅行者教育的公共卫生倡议也促进了市场成长。

全球旅行疫苗市场驱动因素

全球旅行疫苗市场的主要驱动因素是各地感染疾病日益流行，以及人们对安全旅行体验的需求不断增长。随着国际旅行的日益便捷，旅客对目的地特定疾病带来的健康风险也越来越重视。这种日益增强的意识，加上各国政府为推广旅游相关疾病疫苗接种所采取的倡议，正在推动疫苗需求的成长。此外，鑑于近期新冠疫情，全球疫苗接种运动进一步增加了旅客接种必要疫苗的需求，从而促进了市场成长，因为医疗服务提供者和旅客都在寻求积极主动的措施来确保旅行期间的健康安全。

限制全球旅行疫苗市场的因素

全球旅行疫苗市场的主要限制因素之一是疫苗犹豫情绪日益高涨，这主要是由于关于疫苗的错误讯息和文化观念造成的。这种日益增长的怀疑影响了旅客在旅行前接种所需疫苗的意愿，最终限制了市场的成长潜力。此外，与疫苗相关的争议不断增加，反疫苗情绪透过社群媒体平台传播，进一步加剧了公众的焦虑，导致疫苗接种率下降。因此，医疗服务提供者在推广旅游疫苗方面可能会面临挑战。由于潜在旅行者更倾向于个人信念和错误讯息而非医疗建议，整体市场扩张和公共卫生倡议可能会受到阻碍。

全球旅行疫苗市场趋势

随着mRNA、重组和单剂量平台等先进疫苗技术的整合，全球旅行疫苗市场正经历重大变革时期。这些创新透过提高疫苗稳定性增强其效力，优化分发能力，并能对新出现的健康威胁做出快速反应。鑑于mRNA平台在新冠疫情期间取得的显着成功，领先的製药公司正在加大对新型和结合型旅游疫苗的研发投入。这种积极主动的策略不仅满足了现代旅客不断变化的需求，也预见了疫苗监管法规的潜在变化，从而确保市场环境的反应性和韧性。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球旅行疫苗市场规模（依疫苗类型划分）及复合年增长率（2026-2033 年）

• 单剂疫苗
• 联合疫苗

全球旅行疫苗市场规模（按疾病和复合年增长率划分）（2026-2033 年）

• 甲型肝炎
• B型肝炎
• 伤寒
• 黄热病
• 狂犬病
• 脑膜炎奈瑟菌
• 日本脑炎
• 麻疹和腮腺炎
• 其他的

全球旅行疫苗市场规模（按旅行者类型划分）及复合年增长率（2026-2033 年）

• 海外旅客
• 入境旅客
• 商务旅行
• 休閒旅游

全球旅行疫苗市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• GlaxoSmithKline plc
• Sanofi Pasteur
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Abbott Laboratories
• ALK-Abello A/S
• Bavarian Nordic A/S
• CSL Limited
• AstraZeneca plc
• Dynavax Technologies
• Emergent BioSolutions, Inc.
• Valneva SE
• Takeda Pharmaceutical Company
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech International Ltd.
• Altimmune, Inc.
• LG Chem Ltd.（Life Sciences）
• Hualan Biological Engineering Inc.
• Mitsubishi Tanabe Pharma Corporation

结论与建议

Global Travel Vaccines Market size was valued at USD 4.31 Billion in 2024 and is poised to grow from USD 4.54 Billion in 2025 to USD 6.81 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global travel vaccines market is experiencing significant growth due to multiple factors influencing both demand and supply dynamics. The surge in global travel for leisure, professional, and educational activities has heightened the need for region-specific vaccinations, essential for preventing local infections. The boom in global tourism, particularly eco-tourism and adventure travel, further underscores the necessity for protective immunizations. Increasing public and governmental awareness regarding outbreaks of infectious diseases enhances worldwide vaccine demand. Additionally, regulatory requirements in various countries for vaccination proof create compliance and market opportunities. Innovations in vaccine development techniques, including mRNA and recombinant technologies, are improving efficacy and accelerating production, thereby bolstering reliance on these vaccines. Rising healthcare costs and public health initiatives aimed at enhancing traveler education also contribute to market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Travel Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Travel Vaccines Market Segments Analysis

Global Travel Vaccines Market is segmented by Vaccine Type, Disease, Traveler Type and region. Based on Vaccine Type, the market is segmented into Mono Vaccines and Combination Vaccines. Based on Disease, the market is segmented into Hepatitis A, Hepatitis B, Typhoid, Yellow Fever, Rabies, Meningococcal, Japanese Encephalitis, Measles & Mumps and Others. Based on Traveler Type, the market is segmented into Outbound Travelers, Inbound Travelers, Business Travel and Leisure Travel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Travel Vaccines Market

A key market driver for the Global Travel Vaccines Market is the increasing prevalence of infectious diseases across various regions, alongside the rising demand for safe travel experiences. As international travel becomes more accessible, travelers are more aware of health risks associated with destination-specific diseases. This heightened awareness, combined with government initiatives to promote vaccination for travel-related diseases, propels the demand for vaccines. Moreover, the global push for vaccination in light of recent pandemics further enhances the necessity for travelers to obtain essential vaccinations, thereby driving the market's growth as both healthcare providers and travelers seek proactive measures to ensure health safety during travel.

Restraints in the Global Travel Vaccines Market

One significant market restraint for the global travel vaccines market is the rising hesitancy towards vaccination, driven by misinformation and cultural beliefs surrounding vaccines. This growing skepticism impacts travelers' willingness to receive necessary immunizations before travel, ultimately limiting the market's growth potential. Additionally, the increase in vaccine-related controversies and the spread of anti-vaccine sentiments through social media platforms further exacerbate public apprehension, leading to decreased vaccination rates. Consequently, healthcare providers may face challenges in promoting travel vaccines, as potential travelers prioritize their personal beliefs and misinformation over medical advice, hindering overall market expansion and public health initiatives.

Market Trends of the Global Travel Vaccines Market

The Global Travel Vaccines market is experiencing a significant transformation driven by the integration of advanced vaccine technologies, including mRNA, recombinant, and single-dose platforms. These innovations facilitate faster responses to emerging health threats while enhancing vaccine efficacy and optimizing distribution capabilities, owing to their stability. The efficacy of mRNA platforms was notably highlighted during the pandemic, prompting major pharmaceutical companies to invest in the research and development of new and combination travel vaccines. This proactive approach not only addresses the evolving needs of modern travelers but also anticipates potential shifts in vaccine regulations, ensuring a responsive and resilient market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Travel Vaccines Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Mono Vaccines
• Combination Vaccines

Global Travel Vaccines Market Size by Disease & CAGR (2026-2033)

• Market Overview
• Hepatitis A
• Hepatitis B
• Typhoid
• Yellow Fever
• Rabies
• Meningococcal
• Japanese Encephalitis
• Measles & Mumps
• Others

Global Travel Vaccines Market Size by Traveler Type & CAGR (2026-2033)

• Market Overview
• Outbound Travelers
• Inbound Travelers
• Business Travel
• Leisure Travel

Global Travel Vaccines Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Disease, Traveler Type)
  • US
  • Canada
• Europe (Vaccine Type, Disease, Traveler Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Disease, Traveler Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Disease, Traveler Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Disease, Traveler Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Chem Ltd. (Life Sciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations